Value-based contracts can lower costs for payers, offer pharmaceutical companies valuable feedback about their therapies, and, ultimately, improve the quality of health care.
Javier Gonzalez, PharmD, Chief Growth Officer at Abarca
Advertisement
Articles by Javier Gonzalez, PharmD, Chief Growth Officer at Abarca
Advertisement
Latest Updated Articles
Partnerships Between Medicaid Programs and PBMs Will Shape Future of Health CarePublished: February 1st 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Breaking News: CVS Buys Rite Aid, Bartell Drugs
2
Young Women With Symptomatic Long COVID At Higher Risk of POTS
3
FDA Approves 1-Minute HIV Self-Test
4
Statins and Metformin Improved Survival in Patients With Triple-Negative Breast Cancer
5
